Buffington Mohr McNeal’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-17,878
| Closed | -$648K | – | 131 |
|
|
2016
Q4 | $648K | Sell |
17,878
-455
| -2% | -$16.5K | 0.25% | 70 |
|
|
2016
Q3 | $843K | Sell |
18,333
-375
| -2% | -$17.2K | 0.35% | 57 |
|
|
2016
Q2 | $940K | Sell |
18,708
-80
| -0.4% | -$4.02K | 0.41% | 54 |
|
|
2016
Q1 | $1.01M | Sell |
18,788
-230
| -1% | -$12.3K | 0.44% | 49 |
|
|
2015
Q4 | $1.25M | Buy |
19,018
+2,750
| +17% | +$180K | 0.67% | 33 |
|
|
2015
Q3 | $918K | Sell |
16,268
-70
| -0.4% | -$3.95K | 0.6% | 32 |
|
|
2015
Q2 | $965K | Buy |
16,338
+718
| +5% | +$42.4K | 0.54% | 37 |
|
|
2015
Q1 | $973K | Buy |
15,620
+9,605
| +160% | +$598K | 0.54% | 37 |
|
|
2014
Q4 | $346K | Buy |
6,015
+2,265
| +60% | +$130K | 0.2% | 50 |
|
|
2014
Q3 | $202K | Buy |
+3,750
| New | +$202K | 0.11% | 58 |
|